Promising early studies with pegilodecakin plus immunotherapy in pretreated kidney cancer
A recent phase 1b clinical trial investigated the use of [...]
ESMO 2019: Results from JAVELIN-Renal 101 trial for sarcomatoid kidney cancer
Results from the JAVELIN-Renal 101 clinical trial to assess avelumab [...]
Ilixadencel plus sunitinib combination for metastatic kidney cancer
A combination of ilixadencel plus sunitinib has shown a complete [...]
Telaglenastat/cabozantinib combination shows early activity in metastatic kidney cancer
Telaglenastat is an oral glutaminase inhibitor and this is the [...]
Low PD-L1 associated with long term response to sunitinib
Researchers from France have conducted a study to show that [...]
Savolitinib shows promise in first-in-human phase 1 study in solid tumours
Results from a first-in-human phase 1 study of savolitinib in [...]
Complete response of kidney cancer brain metastases to cabozantinib
A recent case study, reported in Case Reports in Urology, [...]
New drug combination for advanced kidney cancer
Scientists have identified a promising new drug for renal cell [...]
HIF-2α inhibitor shows promise in patients with advanced kidney cancer
A recent phase I/II clinical trial with PT2977, a hypoxia-inducible [...]
Bevacizumab plus erlotinib combination for advanced HLRCC
A recent study, published in Cancer Research and Treatment in [...]
